RELB and diabetes mellitus: The miR-148a/375/9a combined with TFs Stat/Relb/NF-κBs/Irfs acted as core modules regulating inflammation and immune-related signaling pathways, which may contribute to the alleviation of hyperglycemia in the diabetes-DFE group (Figure 3D).